Expression of Concern: Attenuation of NDEA-induced hepatocarcinogenesis by naringenin in rats (Cell Biochemistry & Function, (2020), 31, 6, (511-517), 10.1002/cbf.2929);Attenuation of NDEA-induced hepatocarcinogenesis by naringenin in rats

Cell Biochemistry and Function

Volumn 31, Issue 6, 2013, Pages 511-517

  Subramanian, Perumal ^a   Arul, Duraikannu ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

BAX; Bcl 2; Caspase; Hepatocarcinogenesis; Naringenin

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLINE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NARINGENIN; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; LIVER CANCER; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR ESCAPE; UPREGULATION;

CITRUS; RATTUS;

EID: 84880332738     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3621     Document Type: Erratum

References (33)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
2. Diaz-Cano SJ. General morphological and biological features of neoplasms: integration of molecular findings. Histopathology 2008; 53: 1-19.
3. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 2011; 107: 1127-40.
4. Stoimenov I, Helleday T. PCNA on the crossroad of cancer. Biochem Soc Trans 2009; 37: 605-13.
5. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene 2011; 30: 1615-30.
6. Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) 2011; 3: 279-96.
7. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 2011; 12: 715-23.
8. Luqman S, Pezzuto JM. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 2010; 24: 949-63.
9. Tan AC, Konczak I, Sze DM, Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer 2011; 63: 495-505.
10. Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL. Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 2011; 11: 169-77.
11. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19-34.
12. Shi Y, Dai J, Liu H, et al. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharmacol 2009; 87: 729-35.
13. Ekambaram G, Rajendran P, Magesh V, Sakthisekaran D. Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 2008; 28: 106-12.
14. Jin CY, Park C, Hwang HJ, et al. Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells. Mol Nutr Food Res 2011; 55: 300-9.
15. Sabarinathan D, Mahalakshmi P, Vanisree AJ. Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem 2010; 345: 215-22.
16. Leonardi T, Vanamala J, Taddeo SS, et al. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med (Maywood) 2010; 235: 710-7.
17. Ha WS, Kim CK, Sung SH, Kang CB. Study on the mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J Vet Sci 2001; 2: 53-58.
18. Arul D, Subramanian P, Jayakumar M. Protective role of naringenin on circadian rhythms of liver marker enzymes during N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biol Rhythm Res 2012; 43: 103-111.
19. Bradford Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
21. Thompson HJ, Zhu Z, Jiang W. Weight control and breast cancer prevention: are the effects of reduced energy intake equivalent to those of increased energy expenditure? J Nutr 2004; 134: 3407S-3411S.
22. Taha MM, Abdul AB, Abdullah R, Ibrahim TA, Abdelwahab SI, Mohan S. Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem Biol Interact 2010; 186: 295-305.
23. Khan MS, Devaraj H, Devaraj N. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol 2011; 251: 85-94.
24. Jin CY, Park C, Lee JH, et al. Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol In Vitro 2009; 23: 259-65.
25. Sivaramakrishnan V, Niranjali Devaraj S. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Interact 2009; 180: 353-9.
26. Khan MS, Devaraj H, Devaraj N. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol 2011; 251: 85-94.
27. Qin L, Jin L, Lu L, et al. Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2011; 2: 507-16.
28. Sabarinathan D, Mahalakshmi P, Vanisree AJ. Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chem Biol Interact 2011; 189: 26-36.
29. Liao X, Che X, Zhao W, Zhang D, Bi T, Wang G. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling. Oncol Rep 2010; 24: 1669-76.
30. Noriyuki M, Sumi T, Zhi X, et al. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women. Int J Oncol 2007; 31: 531-6.
31. Small AR, Neagu A, Amyot F, Sackett D, Chernomordik V, Gandjbakhche A. Spatial distribution of VEGF isoforms and chemotactic signals in the vicinity of a tumor. J Theor Biol 2008; 252: 593-607.
32. Bassères DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817-30.
33. Morrison WB. Inflammation and Cancer: A Comparative View. J Vet Intern Med 2012; 26: 18-31.